Literature DB >> 7544573

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging.

H P Hartung1, K Reiners, J J Archelos, M Michels, P Seeldrayers, F Heidenreich, K W Pflughaupt, K V Toyka.   

Abstract

Adhesion molecules are important in T-cell trafficking to sites of inflammation. We determined levels of circulating vascular cell adhesion molecule-1 (VCAM-1), L-selectin, and E-selectin in the serum of 147 patients with definite multiple sclerosis of the remitting-relapsing or secondary progressive type. Soluble VCAM-1 and L-selectin concentrations were increased compared to levels in a large group of control subjects. Levels were highest in patients with gadolinium-enhancing lesions on magnetic resonance imaging (VCAM-1: 1,011 +/- 276 vs 626 +/- 87 ng/ml; L-selectin: 1,130 +/- 272 vs 793 +/- 207 ng/ml [mean +/- standard deviation]; p < 0.0001 vs patients without enhancing lesions). Serum levels of soluble tumor necrosis factor receptor (60 kd) were also raised (2.64 +/- 1.23 vs 2.17 +/- 0.69 ng/ml in subjects with other neurological diseases and 2.1 +/- 0.77 ng/ml in healthy control subjects; p < 0.05). Soluble VCAM-1 and L-selectin levels were correlated to concentrations of soluble tumor necrosis factor receptor. In 13 patients with viral encephalitis, similar observations were made. Raised levels of soluble VCAM-1 and L-selectin probably reflect cytokine-induced endothelial cell and T-lymphocyte/monocyte activation occurring in the process of T-cell migration into the central nervous system. Tumor necrosis factor-alpha may be critically involved.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544573     DOI: 10.1002/ana.410380210

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.

Authors:  Sayonara Rangel Oliveira; Tamires Flauzino; Beatriz Sardinha Sabino; Ana Paula Kallaur; Daniela Frizon Alfieri; Damacio Ramon Kaimen-Maciel; Helena Kaminami Morimoto; Elaine Regina Delicato de Almeida; Marcell Alysson Batisti Lozovoy; Edna Maria Vissoci Reiche; Isaias Dichi; Andréa Name Colado Simão
Journal:  Metab Brain Dis       Date:  2018-05-24       Impact factor: 3.584

3.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

4.  Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.

Authors:  Göksemin Acar; Fethi Idiman; Güldal Kirkali; Serkan Ozakbaş; Gülgün Oktay; Handan Cakmakçi; Egemen Idiman
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

5.  Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.

Authors:  P Wipfler; A Heikkinen; A Harrer; G Pilz; A Kunz; S M Golaszewski; R Reuss; Patrick Oschmann; J Kraus
Journal:  J Neurol       Date:  2012-08-09       Impact factor: 4.849

6.  Cerebrospinal fluid levels of soluble tumour necrosis factor receptor in acute encephalitis.

Authors:  T Ichiyama; T Hayashi; M Nishikawa; S Furukawa
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

7.  Finding New Ways How to Control BACE1.

Authors:  Jarmila Nahálková
Journal:  J Membr Biol       Date:  2022-03-19       Impact factor: 1.843

8.  Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown.

Authors:  Axel Haarmann; Annika Deiss; Jürgen Prochaska; Christian Foerch; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Guido Stoll; Peter Rieckmann; Mathias Buttmann
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

9.  Is MS an inflammatory or primary degenerative disease?

Authors:  Jacek Losy
Journal:  J Neural Transm (Vienna)       Date:  2013-09-06       Impact factor: 3.575

10.  Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.

Authors:  Peter Rieckmann; N Kruse; L Nagelkerken; K Beckmann; D Miller; C Polman; F Dahlke; K V Toyka; H P Hartung; S Stürzebecher
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.